Wednesday, November 18, 2026
BreakingFDA News

FDA Enacts Class I Urgent Recall for Infusion Pump Firmware Due to Upstream Occlusion Sensor Anomalies

The FDA has classified a global recall of large-volume infusion pumps as Class I, warning that intermittent firmware sensor errors can cause unintended interruption of high-risk medication infusions.

NewsKrez Editorial DeskNovember 17, 2026 • 12:29 PM UTC
3 min read10 views
FDA Enacts Class I Urgent Recall for Infusion Pump Firmware Due to Upstream Occlusion Sensor Anomalies
Hospital intravenous infusion delivery station and biomedical monitoring hardware.

The U.S. Food and Drug Administration has posted an urgent Class I recall notice regarding select serial numbers of large-volume smart infusion pumps distributed worldwide. Class I recalls indicate situations where exposure to a violative product carries a reasonable probability of serious adverse health consequences or death.

Root Cause Analysis

Internal engineering evaluations and post-market surveillance alerts identified that a timing vulnerability within firmware versions 4.2.1 through 4.3.0 may fail to recognize upstream air-in-line or pressure occlusion alarms during micro-dose vasopressor administration.

Action Steps for Biomedical Engineering Teams

  • Immediately verify inventory against listed model identifiers and firmware builds.
  • Isolate unverified infusion units from critical care and pediatric units.
  • Apply manufacturer firmware patch v4.3.2 per field safety corrective action protocols.
  • Report any adverse events or infusion discrepancies to FDA MedWatch Form 3500A.
Regulatory Verification & Source Attribution

This intelligence report was compiled and verified by the NewsKrez Editorial & Regulatory Intelligence Desk.

Sponsored Intelligence
Medical Device Software Compliance

Automated 21 CFR Part 820 & ISO 13485 Verification

Explore Solution →